What is the appropriate starting dose of levothyroxine?

Starting Dose of Levothyroxine

For most adults with newly diagnosed primary hypothyroidism and no cardiac risk factors, start levothyroxine at the full replacement dose of 1.6 mcg/kg/day based on actual body weight. 1

Adult Dosing Algorithm

The starting dose depends critically on three patient factors:

1. Standard Adult (Age <60, No Cardiac Disease)

• Start at 1.6 mcg/kg/day (full replacement dose) 1
• This approach is safe and achieves euthyroidism faster than low-dose titration 2
• A prospective randomized trial demonstrated that full-dose initiation caused no cardiac events and reached target TSH 16-20 weeks faster than starting at 25 mcg 2

2. High-Risk Patients (Cardiac Disease, Atrial Fibrillation Risk, or Age >60)

• Start at <1.6 mcg/kg/day (lower starting dose) 1
• Titrate every 6-8 weeks (slower than standard patients) 1
• This conservative approach prevents exacerbation of cardiac symptoms 1

3. Geriatric Patients

• Start at <1.6 mcg/kg/day 1
• Use the same cautious titration as cardiac patients

Critical Dosing Adjustments

Obesity Consideration

• For obese patients (BMI ≥30), actual body weight dosing results in overtreatment
• Consider using lean body mass instead: approximately 2.3 mcg/kg of lean body mass 3
• This prevents the need for frequent dose reductions

Pregnancy

• Pre-existing hypothyroidism: Increase dose by 12.5-25 mcg/day as soon as pregnancy confirmed 1
• New-onset with TSH ≥10: Start 1.6 mcg/kg/day 1
• New-onset with TSH <10: Start 1.0 mcg/kg/day 1

Titration Strategy

• Titrate by 12.5-25 mcg increments every 4-6 weeks until euthyroid 1
• Monitor TSH to guide adjustments (except in secondary/tertiary hypothyroidism—use free T4 instead) 1
• Peak therapeutic effect takes 4-6 weeks to manifest 1

Common Pitfalls to Avoid

1. Starting too low in young, healthy adults: The 25 mcg starting dose is outdated for most patients and delays achieving euthyroidism by months 2

2. Using actual body weight in obesity: This leads to overtreatment—57% of patients started at >12.5 mcg/kg required dose reduction for iatrogenic hyperthyroidism 4

3. Inadequate monitoring interval: Adjusting doses before 4-6 weeks doesn't allow full therapeutic effect assessment 1

4. Ignoring cardiac status: Always screen for cardiac disease, arrhythmias, and age >60 before choosing full-dose initiation 1

5. Doses >200 mcg/day: Rarely required and suggest poor compliance, malabsorption, or drug interactions 1